Therapies and Vaccination for Cardiovascular Diseases

Atherosclerosis is that the major cause of acute cardiovascular events such as myocardial infarction and stroke. Current therapies focusing on risk factor reduction, primarily by treatment with sterol lowering statins, have tested to cut back the danger of ischaemic cardiovascular events by up to 400th in randomised clinical trials. Though this has considerably down cardiovascular disease mortality, the majority of patients treated with medicine medical aid are still without effective CVD protection. Through experimental, clinical and medical specialty research, therefore, targeting the inflammatory disease method within the coronary-artery disease plaque represents an exciting new frontier for medical aid development.

 

  • antigen-specific Treg cells
  • Immune tolerance to atherosclerotic antigens
  • Anti-CD3 antibodies
  • Anti-CD3 antibodies
  • IL-2 and IL-2/anti-IL-2 immune complex
  • Vitamin D3
  • Tolerogenic vaccines

Related Conference of Therapies and Vaccination for Cardiovascular Diseases

June 25-26, 2020

22nd Global Obesity Meeting

Tokyo, Japan

Therapies and Vaccination for Cardiovascular Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in